Trial intelligence / Profile preview

Gengke Capsule for Ischemic Stroke Recovery (Phase III)

CTR20132901Phase 3Active

Sponsor
Shaanxi New Medicine Technology Development Center
Start
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ginkgo total lactone in brain infarction, sponsored by Shaanxi New Medicine Technology Development Center. Started Mar 2014; status: active.

02

Drugs

ginkgo total lactone
03

Conditions

brain infarction

Beyond the preview

Go deeper on CTR20132901.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20132901.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call